Target intelligence / Profile preview

Microorganism membrane

Molecular classification
Other
01

Overview

Microorganism membranes are lipid bilayer structures found in prokaryotic and certain eukaryotic microbes that physically separate the cell's interior from the external environment, maintaining cellular integrity and enabling selective transport of nutrients and waste. In bacteria, the membrane comprises primarily phospholipids and proteins and functions in transport, energy production (respiration, sometimes photosynthesis), and the synthesis of critical cellular components. Specialized domains and surface proteins mediate interactions with the environment and other cells. Drug discovery and antimicrobial therapy commonly target membrane integrity and biosynthesis, making them crucial in infectious diseases. However, "Microorganism membranes" is not a standard therapeutic target like a receptor or enzyme; it is a structural entity encompassing multiple components. Thus, this entry is too broad and not specific to an individual target molecule or receptor, and should be considered an incorrect target for structured molecular pharmacology databases.

Other names
cell membraneplasma membranecytoplasmic membrane (bacteria)bacterial membranemicrobial membrane
02

Mechanism of action

Disruption of membrane integrity or permeability (e.g., pore formation, detergent-like action); Inhibition of lipid, protein, or cell wall biosynthetic pathways

03

Biological functions

Barrier to external environmentSelective transport of moleculesStructural support and cell shape maintenanceCell signaling and interactionEnergy metabolism (respiration, photosynthesis for bacteria)Biomolecule synthesis (lipids, cell wall components)
04

Disease associations

Infection (role in pathogenicity, antibiotic resistance)Other (target of antimicrobial therapeutics in infectious disease)
05

Safety considerations

Host cell toxicity from drugs targeting microbial membranes (e.g., nephrotoxicity with polymyxins)Non-specific actions leading to collateral damage in microbiota
06

Interacting drugs

Antibiotics targeting cell envelope or membrane synthesis (e.g., polymyxins, daptomycin, amphotericin B, azoles for fungi)

1 more in the full profile.

07

Biomarkers

Membrane-associated proteins or lipids (e.g., LPS for Gram-negative bacteria, lipoteichoic acid for Gram-positive bacteria)Antibiotic susceptibility markers (e.g., altered membrane proteins conferring resistance)

Beyond the preview

Go deeper on Microorganism membrane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microorganism membrane.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call